These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2530463)

  • 1. What role(s) may extracellular matrix, particularly heparan sulfate, play in amyloid of Alzheimer's disease.
    Benditt EP
    Neurobiol Aging; 1989; 10(5):506; discussion 510-2. PubMed ID: 2530463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses.
    Snow AD; Wight TN
    Neurobiol Aging; 1989; 10(5):481-97. PubMed ID: 2682326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
    Bame KJ; Danda J; Hassall A; Tumova S
    J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
    Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM
    Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
    Su JH; Cummings BJ; Cotman CW
    Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.
    Perlmutter LS; Chui HC; Saperia D; Athanikar J
    Brain Res; 1990 Jan; 508(1):13-9. PubMed ID: 2140065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
    Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
    J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders.
    van Horssen J; Wesseling P; van den Heuvel LP; de Waal RM; Verbeek MM
    Lancet Neurol; 2003 Aug; 2(8):482-92. PubMed ID: 12878436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel glycosaminoglycan precursors as anti-amyloid agents part II.
    Kisilevsky R; Szarek WA
    J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease.
    Small DH; Williamson T; Reed G; Clarris H; Beyreuther K; Masters CL; Nurcombe V
    Ann N Y Acad Sci; 1996 Jan; 777():316-21. PubMed ID: 8624106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.
    Buée L; Hof PR; Bouras C; Delacourte A; Perl DP; Morrison JH; Fillit HM
    Acta Neuropathol; 1994; 87(5):469-80. PubMed ID: 8059599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review.
    Ariga T; Miyatake T; Yu RK
    J Neurosci Res; 2010 Aug; 88(11):2303-15. PubMed ID: 20623617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
    Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteoglycans in the pathogenesis of amyloidosis.
    Linker A
    Neurobiol Aging; 1989; 10(5):507-8; discussion 510-2. PubMed ID: 2812216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of nervous tissue proteoglycans relevant to studies on Alzheimer's disease.
    Margolis RU; Margolis RK
    Neurobiol Aging; 1989; 10(5):500-2; discussion 510-2. PubMed ID: 2530461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.
    Buée L; Ding W; Delacourte A; Fillit H
    Brain Res; 1993 Jan; 601(1-2):154-63. PubMed ID: 8431762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein.
    Schubert D; Schroeder R; LaCorbiere M; Saitoh T; Cole G
    Science; 1988 Jul; 241(4862):223-6. PubMed ID: 2968652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
    Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of Heparan Sulfate and Heparanase in Amyloid Diseases.
    Li JP; Zhang X
    Adv Exp Med Biol; 2020; 1221():631-645. PubMed ID: 32274729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.